Prior Authorization Appeal Letter Tool
Prior Authorization Appeal Letter Tool
- Content revised annually by AAD members
 - Provides robust clinical documentation
 - Currently supports over 70 drugs
 - New FDA-approved drugs added regularly
 
Member login required | Request practice staff access
Streamline appeals for over 70 dermatology drugs with our letter tool. Create customizable letters with medical rationales and references written by AAD members. Please note that personal information entered into the prior authorization tool is not saved by the AAD nor shared with any entity.
Related AAD/A resources
                        Tool Drugs & Diseases
                    
            View a full list of drugs and dermatologic diseases in the tool.
                        Impact on Dermatologists
                    
            Learn about prior authorization’s negative impact on dermatologists.
                        Best Practices
                    
            See our top strategies for streamlining your appeals process.
                        Workflow
                    
            View workflow tips that can help you improve the efficiency of appeals.
                        Resources
                    
            See additional guides and articles to help you with prior authorization.
                        Find a Dermatologist
                        
                        Member directory
                        
                        AAD Learning Center
                        
                        2026 AAD Annual Meeting
                        
                        Need coding help?
                        
                        Reduce burdens
                        
                        Clinical guidelines
                        
                        Why use AAD measures?
                        
                        New insights
                        
                        Physician wellness
                        
                        Joining or selling a practice?
                        
                        Promote the specialty
                        
                        Advocacy priorities